Reshape Lifesciences Inc

CUSIP 76090R408COM NEWOBLNEURQ3 2025

Reshape Lifesciences Inc — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

9.8%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

4 filings · latest Aug 14, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Aug 14, 2025	Cvi Investments, Inc.	13G/A	—	49	SEC
2	Aug 14, 2025	L1 Capital Global Opportunities Master Fund, Ltd.	13G/A	0.3%	7.9K	SEC
3	Aug 13, 2025	Ayrton Capital LLC	13G/A	—	80	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Kovitz Investment Group Partners, LLC	14.6K	$75.8K